Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MSC Based Therapies to Prevent or Treat BPD—A Narrative Review on Advances and Ongoing Challenges
Maurizio J. Goetz, Sarah Kremer, Judith Behnke, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 3, pp. 1138-1138
Open Access | Times Cited: 16

Showing 16 citing articles:

When inflammation meets lung development—an update on the pathogenesis of bronchopulmonary dysplasia
Lena Holzfurtner, Tayyab Shahzad, Ying Dong, et al.
Molecular and Cellular Pediatrics (2022) Vol. 9, Iss. 1
Open Access | Times Cited: 36
The potential therapeutic effect of human umbilical cord mesenchymal stem cell-derived exosomes in bronchopulmonary dysplasia
Tianyu Cheng, Min Mao, Yang Liu, et al.
Life Sciences (2024) Vol. 357, pp. 123047-123047
Closed Access | Times Cited: 5
Association of immune cell recruitment and BPD development
Motaharehsadat Heydarian, Christian Schulz, Tobias Stoeger, et al.
Molecular and Cellular Pediatrics (2022) Vol. 9, Iss. 1
Open Access | Times Cited: 19
Gender-specific effects of prenatal polystyrene nanoparticle exposure on offspring lung development
Wenxia Bu, Mengjiao Yu, Xinyi Ma, et al.
Toxicology Letters (2025) Vol. 407, pp. 1-16
Closed Access
Mesenchymal Stem Cell-Derived Extracellular Vesicles for the Treatment of Bronchopulmonary Dysplasia
Yufeng Xi, Rong Ju, Yujia Wang
Frontiers in Pediatrics (2022) Vol. 10
Open Access | Times Cited: 13
Stem/Progenitor Cells and Related Therapy in Bronchopulmonary Dysplasia
Manuela Marega, Natalia El-Merhie, Mira Y. Gökyildirim, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 11229-11229
Open Access | Times Cited: 7
Oxygen Toxicity to the Immature Lung—Part I: Pathomechanistic Understanding and Preclinical Perspectives
Yesi Choi, Lisa Rekers, Ying Dong, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11006-11006
Open Access | Times Cited: 16
Oxygen Toxicity to the Immature Lung—Part II: The Unmet Clinical Need for Causal Therapy
Judith Behnke, Constanze M. Dippel, Yesi Choi, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10694-10694
Open Access | Times Cited: 12
Mesenchymal Stromal Cells for the Treatment of Interstitial Lung Disease in Children: A Look from Pediatric and Pediatric Surgeon Viewpoints
Glória Pelizzo, Serena Silvestro, Maria Antonietta Avanzini, et al.
Cells (2021) Vol. 10, Iss. 12, pp. 3270-3270
Open Access | Times Cited: 10
TRAIL protects the immature lung from hyperoxic injury
Tayyab Shahzad, Cho‐Ming Chao, Stefan Hadžić, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 7
Open Access | Times Cited: 7
New Sources, Differentiation, and Therapeutic Uses of Mesenchymal Stem Cells
Saeyoung Park, Sung‐Chul Jung
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 10, pp. 5288-5288
Open Access | Times Cited: 8
Comparison of Biological Characteristics of Human Umbilical Cord Wharton’s Jelly-Derived Mesenchymal Stem Cells from Extremely Preterm and Term Infants
Peng Huang, Xiaofei Qin, Chuiqin Fan, et al.
Tissue Engineering and Regenerative Medicine (2023) Vol. 20, Iss. 5, pp. 725-737
Open Access | Times Cited: 3
Phase I trial of human umbilical cord-derived mesenchymal stem cells for treatment of severe bronchopulmonary dysplasia
Yunqiu Xia, Tingyuan Lang, Yuqin Niu, et al.
Genes & Diseases (2022) Vol. 10, Iss. 2, pp. 521-530
Open Access | Times Cited: 5
Development of a new treatment for preterm birth complications using amniotic fluid stem cell therapy.
Yuhsi Abe, Yu Sato, Mamoru Tanaka, et al.
PubMed (2023) Vol. 38, Iss. 9, pp. 965-974
Closed Access | Times Cited: 2
Insights into the Black Box of Intra-Amniotic Infection and Its Impact on the Premature Lung: From Clinical and Preclinical Perspectives
Ying Dong, Stefano Rivetti, Arun Lingampally, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9792-9792
Open Access | Times Cited: 4
Mesenchymal stem cell therapy and its application to bronchopulmonary dysplasia of the preterm neonate. A review
Gustavo Rocha
Portuguese Journal of Pediatrics (2023) Vol. 54, Iss. 3
Open Access
Page 1

Scroll to top